Interferon Regulatory Factor 1 Polymorphisms Previously Associated with Reduced HIV Susceptibility Have No Effect on HIV Disease Progression

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Sivro, Aida ^a   McKinnon, Lyle R ^b,c   Ji, Hezhao ^d   Kimani, Joshua ^a,b   Jaoko, Walter ^b   Plummer, Francis A ^a,d   Su, Ruey Chyi ^a   Ball, T Blake ^a,b,d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c UNIVERSITY OF TORONTO   (Canada)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INTERFERON REGULATORY FACTOR 1; VIRUS RNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE STRUCTURE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION SENSITIVITY; IRF1 GENE; KENYA; MAJOR CLINICAL STUDY; MICROSATELLITE REGION; PATHOGENESIS; PROSTITUTION; PROTEIN LOCALIZATION; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON REGULATORY FACTOR-1; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; SEX WORKERS; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84879161120     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066253     Document Type: Article

References (26)

1. Marsili G, Remoli AL, Sgarbanti M, Battistini A, (2004) Role of acetylases and deacetylase inhibitors in IRF-1-mediated HIV-1 long terminal repeat transcription. Ann N Y Acad Sci 1030: 636-643 doi:10.1196/annals.1329.074.
2. Sgarbanti M, Borsetti A, Moscufo N, Bellocchi MC, Ridolfi B, et al. (2002) Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors. J Exp Med 195: 1359-1370.
3. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, et al. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472: 481-485 doi:10.1038/nature09907.
4. Horton RE, McLaren PJ, Fowke K, Kimani J, Ball TB, (2010) Cohorts for the Study of HIV-1-Exposed but Uninfected Individuals: Benefits and Limitations. J INFECT DIS 202: S377-S381 doi:10.1086/655971.
5. MacDonald KS, Fowke KR, Kimani J, Dunand VA, Nagelkerke NJ, et al. (2000) Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J INFECT DIS 181: 1581-1589 doi:10.1086/315472.
6. Plummer FA, Ball TB, Kimani J, Fowke KR, (1999) Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop? Immunology letters 66: 27-34.
7. Ball TB, Ji H, Kimani J, McLaren P, Marlin C, et al. (2007) Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS 21: 1091-1101 doi:10.1097/QAD.0b013e3280ef6ae1.
8. Burgener A, Rahman S, Ahmad R (2011) Comprehensive Proteomic Study Identifies Serpin and Cystatin Antiproteases as Novel Correlates of HIV-1 Resistance in the Cervicovaginal Mucosa of Female Sex Workers- Journal of Proteome Research (ACS Publications). Journal of proteome.
9. Burgener A, Boutilier J, Wachihi C, Kimani J, Carpenter M, et al. (2008) Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers. J Proteome Res 7: 4446-4454 doi:10.1021/pr800406r.
10. Ji H, Ball TB, Kimani J, Plummer FA, (2004) Novel interferon regulatory factor-1 polymorphisms in a Kenyan population revealed by complete gene sequencing. Journal of human genetics 49: 528-535 doi:10.1007/s10038-004-0185-9.
11. Ji H, Ball TB, Ao Z, Kimani J, Yao X, et al. (2010) Reduced HIV-1 long terminal repeat transcription in subjects with protective interferon regulatory factor-1 genotype: a potential mechanism mediating resistance to infection by HIV-1. Scand J Infect Dis 42: 389-394 doi:10.3109/00365540903496536.
12. Su R-C, Sivro A, Kimani J, Jaoko W, Plummer FA, et al. (2011) Epigenetic control of IRF1 responses in HIV-exposed seronegative versus HIV-susceptible individuals. Blood 117: 2649-2657 doi:10.1182/blood-2010-10-312462.
13. Kaul R, Rowland-Jones SL, Kimani J, Dong T, Yang H-B, et al. (2001) Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. J Clin Invest 107: 341-349 doi:10.1172/JCI10714.
14. Fowke K, Nagelkerke N, Kimani J (1996) ScienceDirect.com- The Lancet- Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. The Lancet.
15. McNeil AJ, (1997) Bayes estimates for immunological progression rates in HIV disease. Stat Med 16: 2555-2572.
16. Lipsitz SR, Ibrahim J, Molenberghs G, (2000) Using a Box-Cox transformation in the analysis of longitudinal data with incomplete responses. J R Statist Soc C 49: 287-296 doi:10.1111/1467-9876.00192.
17. Yang H, Wu H, Hancock G, Clutton G, Sande N, et al. (2012) Antiviral Inhibitory Capacity of CD8+ T cells Predicts the Rate of CD4+ T-Cell Decline in HIV-1 Infection. J INFECT DIS. doi:10.1093/infdis/jis379.
18. McKinnon LR, Nagelkerke NJ, Kaul R, Shaw SY, Capina R, et al. (2012) HIV-1 Clade D Is Associated with Increased Rates of CD4 Decline in a Kenyan Cohort. PLoS ONE 7: e49797 doi:10.1371/journal.pone.0049797.
19. World Health Organization (2010), Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach, Available: http://www.who.int/hiv/pub/arv/adult2010/en/index.html. Accessed 2013, May 14.
20. Rodríguez B, Sethi AK, Cheruvu VK, Mackay W, Bosch RJ, et al. (2006) Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 296: 1498-1506 doi:10.1001/jama.296.12.1498.
21. Sobieszczyk ME, Lingappa JR, McElrath MJ (2011) Host genetic polymorphisms associated with innate immune factors and HIV-1. Current Opinion in HIV and AIDS: 1. doi:10.1097/COH.0b013e3283497155.
22. Harman AN, Lai J, Turville S, Samarajiwa S, Gray L, et al. (2011) HIV infection of dendritic cells subverts the interferon induction pathway via IRF1 and inhibits type 1 interferon production. Blood. doi:10.1182/blood-2010-07-297721.
23. Harman A, Lai J, Turville S (2011) HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production.
24. Haase A (2005) Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol.
25. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, et al. (2008) Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proceedings of the National Academy of Sciences 105: 7552-7557 doi:10.1073/pnas.0802203105.
26. Marsili G, Remoli AL, Sgarbanti M, Perrotti E, Fragale A, et al. (2012) HIV-1, interferon and the interferon regulatory factor system: An interplay between induction, antiviral responses and viral evasion. Cytokine & Growth Factor Reviews. doi:10.1016/j.cytogfr.2012.06.001.